Benzodiazepine deaths increased from April-June 2019 to April-June 2020, with larger increase for illicit benzodiazepine deaths

Odds increased for developing alcohol use disorders, cannabis use disorders, other drug use disorders

Odds increased for developing alcohol use disorders, cannabis use disorders, other drug use disorders

However, survivors had more problems with mobility, pain or discomfort, anxiety or depression at one year than controls

Findings show noninferior outcomes at three months versus cognitive behavioral therapy

Findings based on a systematic literature review of studies reporting the use of ketamine, esketamine for treatment-resistant depression

Vaccine hesitancy highest among Black and Hispanic or Latino health care workers; concerns include side effects, newness of vaccine